SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)

Clinical trials for SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) explained in plain language.

Never miss a new study

Get alerted when new SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) trials appear

Sign up with your email to follow new studies for SYSTEMIC LUPUS ERYTHEMATOSUS (SLE), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 41 Not yet recruiting 10 Not yet finished but already full! 6 Completed 8 Terminated 1

Experimental CAR t therapy targets lupus and related diseases – but trial ends early

Disease control Terminated

This early-phase trial tested a single infusion of IMPT-514, a personalized CAR T cell therapy, in 3 adults with severe lupus, vasculitis, or inflammatory myopathy that did not respond to standard treatments. The goal was to check safety and see if the therapy could reset the imm…

Matched conditions: SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)

Phase: EARLY_PHASE1 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control

Last updated Jun 15, 2026 19:07 UTC

SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)

Get alerted when new SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) trials appear

Experimental CAR t therapy targets lupus and related diseases – but trial ends early